Overview

The Gut Microbiota in Obsessive-Compulsive Disorder

Status:
Completed
Trial end date:
2016-03-01
Target enrollment:
Participant gender:
Summary
This study will examine the gut microbiota and serum inflammatory markers in patients with Obsessive-Compulsive Disorder vs. healthy controls. Phase II of the study will examine the gut microbiota and cytokine levels following 12-weeks of treatment with Selective Serotonin Reuptake Inhibitors (SSRIs).
Phase:
N/A
Details
Lead Sponsor:
McMaster University
Collaborator:
Hamilton Health Sciences Corporation
Treatments:
Citalopram
Fluoxetine
Fluvoxamine
Paroxetine
Serotonin
Serotonin Uptake Inhibitors
Sertraline